TL;DR
This study investigated the safety and efficacy of a low-energy femtosecond laser-assisted cataract surgery (FLACS) compared to conventional phacoemulsification (CP) in Chinese patients. The findings indicate that FLACS is non-inferior to CP, with a notable advantage of a significantly lower increase in central corneal thickness (CCT) in the early postoperative period.
What Problem Does This Paper Address?
Cataract surgery is a common procedure, but conventional phacoemulsification can cause damage to the corneal endothelium due to ultrasonic energy. Femtosecond laser-assisted cataract surgery (FLACS) has emerged as an alternative, aiming to reduce this damage by automating steps like capsulotomy and lens fragmentation. However, traditional FLACS systems often involve higher costs, longer operating times, and the need for multiple operating rooms, limiting their widespread adoption. This paper addresses the need for a more accessible and efficient FLACS approach by evaluating a specific low-energy femtosecond laser system (FEMTO LDV Z8) that is designed for single-room use and potentially reduced operating time. The study aims to determine if this particular low-energy FLACS system offers comparable safety and efficacy to conventional methods, particularly in a Chinese patient population.
Methods
This was a prospective, multicenter, interventional, randomized controlled trial involving 126 patients. Participants were randomly assigned in a 1:1 ratio to undergo either FLACS using the low-energy FEMTO LDV Z8 laser or conventional phacoemulsification (CP). The primary endpoint was the comparison of endothelial cell loss (ECL) at 3 months post-surgery. Secondary endpoints included cumulative dissipated energy (CDE), changes in central corneal thickness (CCT), and visual acuities (uncorrected and corrected distance visual acuity - UDVA and CDVA). Patients were followed up at 1 day, 7 days, 1 month, and 3 months post-surgery. Endothelial cell density (ECD) was measured using specular microscopy, and CCT was measured using Pentacam HR. Statistical analyses included independent t-tests, Mann-Whitney U tests, Chi-squared tests, and generalized linear regression models to account for baseline ECD, CCT, and clinical center covariates. A non-inferiority approach was used for sample size calculations and the primary outcome assessment.
Datasets
Not discussed in the paper. The study involved patient data collected during the clinical trial.
Key Insights and Ideas
- Low-energy FLACS shows promise for corneal health: The most significant finding is the statistically significant lower increase in central corneal thickness (CCT) observed in the FLACS group at Day 7 post-surgery. This suggests that the low-energy femtosecond laser may be gentler on the cornea, potentially leading to faster recovery of corneal function.
- Non-inferiority established: The study successfully demonstrated that the low-energy FLACS approach is non-inferior to conventional phacoemulsification in terms of preserving endothelial cell density (ECL) at 3 months. This is a crucial finding for the adoption of new technologies.
- Single-room efficiency is a key advantage: While not explicitly a "finding" in the results section, the paper highlights the design of the FEMTO LDV Z8 system for single-room use, which addresses a major practical barrier to FLACS adoption. This implies potential for reduced operating time and improved workflow.
- CDE is comparable, but trends favor FLACS: Although not statistically significant, the mean cumulative dissipated energy (CDE) was lower in the FLACS group, aligning with the general expectation that femtosecond lasers reduce the energy needed for phacoemulsification.
Key Results
- Endothelial Cell Loss (ECL): FLACS was found to be non-inferior to CP for mean ECL at 3 months (-409.3 vs. -436.9 cells/mm²). While the FLACS group showed a trend towards lower ECL at all time points, the differences were not statistically significant.
- Central Corneal Thickness (CCT): The FLACS group showed a statistically significantly lower increase in CCT at Day 7 (4.9 µm vs. 9.2 µm; P=0.04). This trend persisted at 1 and 3 months but was not statistically significant.
- Cumulative Dissipated Energy (CDE): Mean CDE was lower in the FLACS group (4.1 vs. 4.5 percent-seconds), but the difference was not statistically significant (P=0.51).
- Visual Acuity: Postoperative uncorrected and corrected distance visual acuities (UDVA and CDVA) were comparable between the two groups.
- Surgery Time: Conventional phacoemulsification was faster, with the CP group showing shorter surgery time (P=0.015). However, the paper notes that the FLACS system's single-room design mitigates some of the time penalties seen in other FLACS studies.
- Complications: No intraoperative complications were observed in either group. The rate of postoperative complications was comparable between the groups.
Limitations and Future Work
The authors acknowledge a few limitations:
- Small sample size: The study included 126 patients, which they note is a limitation.
- Short follow-up period: The follow-up was limited to 3 months.
Future work suggested includes:
- Larger patient volumes and longer follow-ups: To better assess the long-term clinical efficacy and safety of low-energy FLACS.
- Cost-benefit analysis: To evaluate the economic viability of this emerging FLACS technology compared to conventional methods.
- Further research into variations: The authors suggest future research to decipher and better delineate factors responsible for variations in outcomes observed across different studies.
Summary updated